FDA Accepts ANDA for Viloxazine Hydrochloride by Appco Pharma
The FDA has accepted the ANDA for Viloxazine Hydrochloride submitted by Appco Pharma.
Company
Pharmaceutical intelligence for Appco Pharma with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.